Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial membrane potential (MMP) in Trypanosoma species is a vital electrochemical gradient across the inner mitochondrial membrane that is essential for parasite survival (Vercesi et al., 2006). In the bloodstream form of Trypanosoma brucei, this potential is uniquely maintained by the F1Fo-ATP synthase (Complex V) operating in reverse, which pumps protons out of the matrix at the expense of ATP (Schnaufer et al., 2005). This gradient is indispensable for the import of nuclear-encoded mitochondrial proteins and the regulation of ion homeostasis, particularly calcium (Meehan et al., 2015). Because the maintenance of MMP in certain trypanosome life stages relies on mechanisms distinct from those in mammalian cells, it represents a vulnerable phenotypic target for chemotherapy (Fidalgo & Gille, 2011). Several existing trypanocides, including pentamidine and diminazene, are known to accumulate in the mitochondrion and disrupt this potential, leading to metabolic collapse (Meehan et al., 2015). However, targeting this process requires high selectivity to avoid host mitochondriotoxicity, as the fundamental physics of the membrane potential is conserved across eukaryotes (Vercesi et al., 2006). Experimental compounds like rhodamine derivatives and dequalinium also target this potential by acting as lipophilic cations that accumulate in the negatively charged mitochondrial matrix (Fidalgo & Gille, 2011). Monitoring the MMP using fluorescent dyes like JC-1 or Rhodamine 123 is a standard method for assessing the efficacy of new trypanocidal candidates in phenotypic screens (Vercesi et al., 2006). Overall, while not a single molecular entity, the maintenance of the mitochondrial membrane potential is a validated physiological target for treating African trypanosomiasis and Chagas disease.
Dissipation of the mitochondrial membrane potential and inhibition of mitochondrial bioenergetics
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial membrane potential (MMP) (MMP).